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Abstract
Background: Recombination is an important mechanism in the generation of genetic diversity of the human (HIV)
and simian (SIV) immunodeficiency viruses. It requires the co-packaging of divergent RNA genomes into the same
retroviral capsid and subsequent template switching during the reverse transcription reaction. By HIV-specific
fluorescence in situ hybridization (FISH), we have previously shown that the splenocytes from 2 chronically infected
patients with Castelman’s disease were multi-infected and thus fulfill the in vivo requirements to generate genetic
diversity by recombination. In order to analyze when multi-infection first occurs during a lentivirus infection and
how the distribution of multi-infection evolves during the disease course, we now determined the SIV copy
numbers from splenocytes of 11 SIVmac251-infected rhesus macaques cross-sectionally covering the time span of
primary infection throughout to end-stage immunodeficiency.
Results: SIV multi-infection of single splenocytes was readily detected in all monkeys and all stages of the
infection. Single-infected cells were more frequent than double- or triple- infected cells. There was no strong trend
linking the copy number distribution to plasma viral load, disease stage, or CD4 cell counts.
Conclusions: SIV multi-infection of single cells is already established during the primary infection phase thus
enabling recombination to affect viral evolution in vivo throughout the disease course.
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Background
The human (HIV) and simian (SIV) immunodeficiency
viruses exhibit phenomenal genetic diversity. This diver-
sity is generated by 3 different mechanisms, (i) error-
prone replication by the reverse transcriptase that
occurs without proofreading [1], (ii) hypermutation by
host mutators of the family of cytidine deaminases [2-6]
and (iii) recombination between the viral RNA genomes
by template switching [7]. As a result of these processes,
a population of virus variants or quasispecies is estab-
lished within an infected host that is subsequently
shaped by processes like fitness competition between
variants, immune-mediated activation of infected cells
and bottlenecking [8-11].
Due to the structure of the retrovirus particle and the
low processivity of the reverse transcriptase, recombina-
tion is extraordinary frequent in HIV and SIV [12]. In
fact, the number of crossovers during reverse transcrip-
tion between the two RNA templates that are packaged
within one HIV virion has been estimated to be around
three or higher per genome [13-16]. Thus any generated
single provirus can be expected to have a mosaic struc-
ture derived from its two parental viral RNA strands. In
comparison, the point mutation rate with approximately
0.25 mutations per genome and replication [17] is at
least a factor of 10 lower.
To have an impact on virus evolution, recombination
needs to proceed between non-identical RNA strands.
The requirements and biological steps for the generation
of such virus particles with non-identical genomes have
been described. First, multi-infection of single cells
occurs via direct and via cell-mediated entry pathways
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[18]. Second, the existence of multi-infected cells has
been directly shown by HIV-specific fluorescence in situ
hybridization (FISH) on splenocytes of infected patients
[19]. Third, transcribed HIV RNA genomes are co-pack-
aged into virions at ratios expected from a random dis-
tribution [20]. However, the extent of sequence
similarity, especially of the dimerization initiation site,
influences co-packaging efficiency and consequently the
frequency of observable recombinants [21-23].
While features of the basic steps in the generation of
HIV/SIV recombinants have been described in various
experimental conditions, it is still unknown when multi-
infected single cells first appear in vivo during a lentivirus
infection and how the distribution of multi-infection
evolves during the disease course. To answer these ques-
tions, we determined the SIV copy number in splenocytes
from SIVmac251-infected rhesus macaques (Macaca
mulatta) by specific fluorescence in situ hybridization.
Results and discussion
Multi-infection of single splenocytes of SIV-infected
rhesus macaques in all stages of infection
To determine the SIV copy number of splenocytes from
SIVmac251-infected animals by FISH, DNA from SIV-
mac239 was used as a probe. This was possible due to the
high sequence homology between SIVmac239 and SIV-
mac251 [24]. In vitro SIVmac239-infected CEMx174 cells
served as positive control to test the sensitivity of the bio-
tin-labelled SIV DNA-probe while un-infected CEMx174
cells as well as spleen cells from an un-infected rhesus
macaque were used as negative controls. Only after detect-
ing bright signals in the interphase nuclei of the infected
CEMx174 cells with no nonspecific background in the
negative samples, the splenocytes of the infected animals
were analyzed under the same conditions.
Multi-SIV-infected cells were observed for all animals
and throughout the entire observation period from pri-
mary infection (2 weeks post infection) to the AIDS state
(animals 1740, 1778 and 1718; Figure 1 and Table 1).
The relative distribution of provirus copy numbers was
similar from the acute to the late stage of infection. With
the exception of monkey 1778, cells with 1 provirus copy
were more frequent than cells with 2 or 3 copies. Three
provirus copies/cell were detected in 2 monkeys at 2
weeks and 51 weeks post infection, respectively. Thus
multi-infection of single splenocytes is a general phe-
nomenon that occurs during all stages of an SIV
infection.
To evaluate the efficiency of the FISH assay and the
error in our provirus copy number estimates, the techni-
que has to be tested on cells with a defined copy number.
For this we used U1 cells that carry 2 HIV provirus
copies per genome and performed the assay under identi-
cal conditions only using HIV DNA as a probe. This is a
valid approach as the base composition and thus the
hybridization properties for HIV-1 and SIV are basically
identical (HIV-1: A-35,3%, T-22,1%, G-24,4%, C-18,2%
and SIV239: A-33,6%, T-22,7%, G-24,7%, C-18,8%).
Approximately 10% of U1 cells showed only one copy.
Thus it would appear that we underestimated the real
values by ~10%. Within the same experiments, we very
rarely detected 3 proviruses (< 0.5% of cells). Likewise,
using either HIV DNA or SIV DNA as probes, non-
infected monkey splenocytes rarely gave a positive signal
(< 0.5%) suggesting that the number of false positive
events is very small. Extrapolating these findings to the
SIV FISH experiments with splenocytes from infected
monkeys, the real SIV proviral copy number may be
around 10% higher than indicated.
While the sample size of this present study is low and
thus has limited statistical power, there was no strong
trend between the SIV plasma viral load, the stage of SIV
infection, or the CD4 cell count and the relative copy
number distribution. For example, monkeys 8179 and
1740 differed more than 104-fold in plasma virus titres but
showed a similar provirus distribution in their splenocytes
(Table 1). A similar observation was made previously
when studying the HIV copy number distributions in sple-
nocytes of 2 seropositive patients with Castleman disease
[19]. Notably, in this latter study, the copy number distri-
bution was higher with the majority of cells harbouring 3
to 4 proviruses. While the reason for this difference is
unknown, it may well be related to the lymphoproliferative
nature of the disease [25]. Nonetheless, with respect to
recombination, any cell with a provirus copy number
above 1 is able to generate virions with mixed RNA gen-
omes that in the subsequent infection round will result in
recombinant progeny.
How are infected splenocytes with multiple proviruses
generated? The lack of a clear trend between the plasma
viral load and the copy number distribution of this study
and that of Jung et al. [19] suggest that cell-cell transmis-
sion events rather than circulating virus itself are the likely
viral source. Indeed, infections by viruses deposited on
Follicular Dendritic cells [26] or transferred from Dendri-
tic cells to T cells in the process of antigen-specific stimu-
lation [27] are highly efficient and may result in the
transmission of multiple virions as demonstrated by more
recent ex vivo studies [28,29].
The early onset of SIV multi-infection provides the fun-
damental mechanistic requirements for recombination to
occur already at primary viremia. Indeed, when macaques
were inoculated simultaneously with SIVmac239Δvpx or
Δvpr and SIVmac239Δnef, the emergence of wild-type
virus was detected in blood in as little as 2 weeks post-
inoculation [30,31]. This was due to the large fitness
advantage of the recombined wild-type over both deletion
mutants. In naturally occurring HIV infections however,
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only one or very few virus variants are transmitted result-
ing in a rather homogenous virus population at primary
viremia [32,33]. Consequently, any generated recombinant
will remain unnoticed unless a fair degree of sequence
diversity is generated over time by error prone replication
rounds. This scenario is well documented and shows up in
the time-structured sequence networks from HIV patients
as well as clonal SIV infections of macaques [34-37].
Conclusions
In summary, SIV multi-infection of single cells within a
lymphoid tissue is established during the primary infec-
tion phase and observed throughout the entire disease
course. As a consequence, recombination events will
inevitably occur and contribute to virus evolution.
Methods
Splenocytes were analyzed from 11 SIVmac251-infected
monkeys that had been used in previously published
infection studies [38]. Animals were housed at the Ger-
man Primate Center under standard conditions and
experiments were performed according to the German
animal protection law which complies with the European
Union guidelines on the use of non-human primates for
biomedical research (approval 604.42502/08-02.95,
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Figure 1 Distribution of the relative SIV provirus copy number in single spleen cells of SIVmac251-infected rhesus macaques. The SIV
copy number was determined with SIV-specific fluorescence in situ hybridization. Results from 4 monkeys are shown. Exact numbers are
indicated in Table 1. Pictures from individual nuclei with different SIV copy numbers are given as examples. Green spots correspond to proviral
SIV-genomes detected with a biotin-labelled SIVmac239Δenv-probe and a biotin-tyramid signal amplification system. W.p.i. = weeks post
infection.
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infected intravenously with 100 MID50 (monkey infec-
tious dose infecting 50% of recipients) of a SIVmac251-
derived virus stock prepared in rhesus monkey peripheral
blood mononuclear cells [39]. They were sacrificed at
predetermined time points in the acute, post-acute, and
early asymptomatic phase without clinical symptoms of
immunodeficiency or euthanized due to early signs of
AIDS. The eleven animals cover a time range from 2
weeks to 51 weeks post primary infection and a wide
range of peripheral CD4 T cell counts (Table 1). The
spleens were removed from anesthetized animals, cut
into slices, and put into ice-cold Hank’s balanced salt
solution containing 3% FCS. Spleen tissue was then
forced through a 100 μm-mesh metal sieve with forceps.
The dissociated material was left to settle for five min-
utes, and the single cell suspension in the supernatant
was collected by centrifugation at 170 g for 10 minutes at
4°C and washed twice. Cells were counted in a Neubauer
chamber and stored in liquid nitrogen. For the SIV-speci-
fic FISH, the thawed cells were stimulated for 2 days in
the presence of 10 μM AZT. The fixed cell nuclei were
then hydridized with a biotin-labelled SIVmac239-speci-
fic DNA probe that was subsequently detected with a tyr-
amide signal amplification (TSA) system. The
fluorescence signals were analysed with an Olympus AX
70 epifluorescence microscope (Olympus Optical, Ham-
burg Germany). Pictures were documented with a digital
camera Hamamatsu DC C4742-95 (Hamamatsu Photo-
nics Deutschland GmbH, Herrsching am Ammersee,
Germany) and an ISIS digital imaging analysis system
(Metasystems GmbH, Altlussheim Germany). A detailed
description of the experimental procedures is given in
the Additional file 1 and Additional file 2.
Additional material
Additional file 1: Detailed protocol for the preparation of cells for
fluorescence in situ hybridization.
Additional file 2: Detailed protocol for the SIV-specific fluorescence
in situ hybridization.
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Table 1 Characteristics of SIVmac251-infected rhesus macaques
Monkey Duration of infection
(weeks)
Absolute CD4+ T cells
(cell/μl)
Plasma viral load (SIV-
RNA/ml)










8310 (I) 0 804 nd - - - -
8326 (I) 2 1980 nd 83 0.77 0.20 0.02
7783 (C) 2 471 nd 125 0.69 0.31 -
8152 (I) 4 nd nd 28 0.82 0.18 -
7793 (C) 7 471 nd 122 0.80 0.20 -
8179 (C) 12 252 7.7 × 103 52 0.73 0.27 -
1740 (I,
A)
13 131 2.3 × 108 77 0.73 0.27 -
7785 (C) 17 910 nd 45 0.67 0.33 -
8159 (I) 18 545 nd 163 0.72 0.28 -
7786 (C) 19 840 nd 111 0.73 0.27 -
1778 (I,
A)
29 571 3, 1 × 106 41 0.49 0.51 -
1718, (I,
A)
51 54 2.6 × 105 93 0.68 0.29 0.03
Relative SIV copy number distribution including the number of infected cells counted and some characteristics of the SIV infection are given for all monkeys
studied. The determined copy numbers are the result of 2 to 4 independent FISH experiments. The standard deviation of individual copy number counts was less
than 10%. Around 200 to 300 non-infected control cells were inspected in each FISH experiment. I = Rhesus macaques of Indian origin; C = Rhesus macaques of
Chinese origin; A = AIDS state.
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